Patients decide how anonymized they want their data to be, but can opt to let medical scientists discover new cures for the ailments that are of interest to you by treating the MediChain data as ‘big data’.
MediChain costs patients and doctors nothing. Patients can choose to sell their data to pharmaceutical companies in an anonymised form to help bring cures to market for the problems that they themselves suffer from.
We are starting from the Medrec system developed at MIT and with key team member heading setting that up as our MVP. We have plans for technology that will increase transaction speed up to 14400x faster than the current state of the art technologies.
This is a market with over 2 000 000 000 Potential Clients. MediChain solves problems multiple $ billion markets including one (drug design) with a market value of $150Bn+ pa.